ACB · Healthcare · $239M
$3.86-4.34%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“해외 의료용 매출이 17% 늘면서 전체 매출의 64%를 차지했어요 — 작년 50%에서 크게 올라간 거예요.”
In the company's words · 2027 1분기 earnings call